Skip to main content
Erschienen in: Journal of Neurology 11/2011

01.11.2011 | Original Communication

Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score

verfasst von: Paolo Invernizzi, Laura Bertolasi, Maria Rachele Bianchi, Marco Turatti, Alberto Gajofatto, Maria Donata Benedetti

Erschienen in: Journal of Neurology | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Evoked potentials (EPs) have long been used as diagnostic tools in multiple sclerosis (MS), although their importance decreased as magnetic resonance imaging (MRI) became available. However, the prognostic value of EPs in MS has not been completely established. The aim of the study was to analyze the prognostic significance of EPs in a cohort of MS cases. From the Verona University Hospital MS Clinic database we retrospectively identified 80 MS patients who underwent a complete neurophysiological evaluation, including visual, brain stem, somatosensory and motor EPs and who were followed for at least 5 years after the study. EPs abnormalities were quantified through an index of global EPs alteration (EP score). The relationship between EP score and disability in terms of Expanded Disability Status Scale (EDSS) was analyzed by the Kaplan–Meier survival method and Spearman ρ correlation coefficient. ROC curves were used to determine the best EP score cut off to predict different EDSS endpoints. For each endpoint, sensitivity, specificity, positive and negative predictive value of EP score were calculated. We found a significant correlation (p < 0.001) between EP score and EDSS score at the time of neurophysiological study and at 1, 3 and 5 years of follow-up, particularly for motor and somatosensory EPs. Kaplan–Meier curves confirmed an increased risk of disability in those patients with EP score higher than the median value. EP score of 8 or 9 showed the highest sensitivity and specificity in predicting EDSS 4.0 and 6.0. EPs are reliable procedures to predict disability in MS patients. The correlation between EPs abnormalities and EDSS is higher than between conventional MRI and EDSS.
Literatur
1.
Zurück zum Zitat Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717PubMedCrossRef Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717PubMedCrossRef
2.
Zurück zum Zitat Lublin FD, Reingold SC, For the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907–911PubMed Lublin FD, Reingold SC, For the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907–911PubMed
3.
Zurück zum Zitat McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinski JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127PubMedCrossRef McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinski JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127PubMedCrossRef
4.
Zurück zum Zitat Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revision to “McDonald Criteria”. Ann Neurol 58:840–846PubMedCrossRef Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revision to “McDonald Criteria”. Ann Neurol 58:840–846PubMedCrossRef
5.
Zurück zum Zitat Swanton JK, Fernando K, Dalton CM, Miskiel KA, Thompson AJ, Plant GT, Miller DH (2006) Modification of MRI criteria for multiple sclerosisin patients with clinically isolated syndromes. J Neurol Neurosug Psychiatry 77:830–833CrossRef Swanton JK, Fernando K, Dalton CM, Miskiel KA, Thompson AJ, Plant GT, Miller DH (2006) Modification of MRI criteria for multiple sclerosisin patients with clinically isolated syndromes. J Neurol Neurosug Psychiatry 77:830–833CrossRef
6.
Zurück zum Zitat Bakshi R, Neema M, Healy BC, Liptak Z, Betansky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttman RG, Weiner HL (2008) Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Arch Neurol 65:1449–1453PubMedCrossRef Bakshi R, Neema M, Healy BC, Liptak Z, Betansky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttman RG, Weiner HL (2008) Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Arch Neurol 65:1449–1453PubMedCrossRef
7.
Zurück zum Zitat Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239–245PubMedCrossRef Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239–245PubMedCrossRef
8.
Zurück zum Zitat Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMed Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMed
9.
Zurück zum Zitat Gawne-Cain ML, O’Riordan JI, Coles A, Newell B, Thompson AJ, Miller DH (1998) MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosug Psychiatry 64:197–203CrossRef Gawne-Cain ML, O’Riordan JI, Coles A, Newell B, Thompson AJ, Miller DH (1998) MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosug Psychiatry 64:197–203CrossRef
10.
Zurück zum Zitat Nijeholt GT, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F (1998) Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121:687–973PubMedCrossRef Nijeholt GT, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F (1998) Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121:687–973PubMedCrossRef
11.
Zurück zum Zitat Charil A, Zijdenbos AP, Taylor J, Boelman C, Worsley KJ, Evans AC, Dagher A (2003) Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19:532–544PubMedCrossRef Charil A, Zijdenbos AP, Taylor J, Boelman C, Worsley KJ, Evans AC, Dagher A (2003) Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19:532–544PubMedCrossRef
12.
Zurück zum Zitat Li DKB, Held U, Petkau J, Daumer M, Barkhof F, Fazekas F, Frank JA, Kappos L, Miller DH, Simon JH, Wolinsky JS, Filippi M, For the Sylvia Lawry Centre for MS research (2006) MRI T2 lesion burden in multiple sclerosis. A plateauing relationship with clinical disability. Neurology 66:1384–1389PubMedCrossRef Li DKB, Held U, Petkau J, Daumer M, Barkhof F, Fazekas F, Frank JA, Kappos L, Miller DH, Simon JH, Wolinsky JS, Filippi M, For the Sylvia Lawry Centre for MS research (2006) MRI T2 lesion burden in multiple sclerosis. A plateauing relationship with clinical disability. Neurology 66:1384–1389PubMedCrossRef
13.
Zurück zum Zitat O’Connor P, Marchetti P, Lee L, Perera M (1998) Evoked potential abnormality scorse are a useful measure of disease burden in relapsing-remitting multiple sclerosis. Ann Neurol 44:404–407PubMedCrossRef O’Connor P, Marchetti P, Lee L, Perera M (1998) Evoked potential abnormality scorse are a useful measure of disease burden in relapsing-remitting multiple sclerosis. Ann Neurol 44:404–407PubMedCrossRef
14.
Zurück zum Zitat Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L (2001) Visual and motor evoked potentials in the course of multiple sclerosis. Brain 124:2162–2168PubMedCrossRef Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L (2001) Visual and motor evoked potentials in the course of multiple sclerosis. Brain 124:2162–2168PubMedCrossRef
15.
Zurück zum Zitat Leocani L, Rovaris M, Boneschi FM, Medaglini S, Rossi P, Martinelli V, Amadio S, Comi G (2006) Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study. J Neurol Neurosurg Psychiatry 77:1030–1035PubMedCrossRef Leocani L, Rovaris M, Boneschi FM, Medaglini S, Rossi P, Martinelli V, Amadio S, Comi G (2006) Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study. J Neurol Neurosurg Psychiatry 77:1030–1035PubMedCrossRef
16.
Zurück zum Zitat Kallman BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K (2006) Early abnormalities of evoked potentials and future disability in patients with multiple sclersosis. Mult Scler 12:58–65CrossRef Kallman BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K (2006) Early abnormalities of evoked potentials and future disability in patients with multiple sclersosis. Mult Scler 12:58–65CrossRef
17.
Zurück zum Zitat Deuschl G, Eisen A (1999) Recommendations for the practice of clinical neurophysiology: guidelines of the international federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol 52(Suppl):192–211 Deuschl G, Eisen A (1999) Recommendations for the practice of clinical neurophysiology: guidelines of the international federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol 52(Suppl):192–211
18.
Zurück zum Zitat Fisher E, Lee JC, Nakamura K, Rudick RA (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64:255–265PubMedCrossRef Fisher E, Lee JC, Nakamura K, Rudick RA (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64:255–265PubMedCrossRef
19.
Zurück zum Zitat Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH (2008) Gray matter atrophy is related to long-term disability in mutiple sclerosis. Ann Neurol 64:247–254PubMedCrossRef Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH (2008) Gray matter atrophy is related to long-term disability in mutiple sclerosis. Ann Neurol 64:247–254PubMedCrossRef
Metadaten
Titel
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score
verfasst von
Paolo Invernizzi
Laura Bertolasi
Maria Rachele Bianchi
Marco Turatti
Alberto Gajofatto
Maria Donata Benedetti
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 11/2011
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6033-x

Weitere Artikel der Ausgabe 11/2011

Journal of Neurology 11/2011 Zur Ausgabe

Pioneers in Neurology

José Aboulker (1920–2009)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.